AnnJi Pharmaceutical Co., Ltd. (TPEX:7754)
Taiwan · Delayed Price · Currency is TWD 60.60
-1.00 (-1.62%)
Apr 17, 2026, 1:38 PM CST
AnnJi Pharmaceutical Revenue
In the year 2025, AnnJi Pharmaceutical had annual revenue of 7.55M TWD, down -92.17%. AnnJi Pharmaceutical had revenue of 419.00K in the half year ending December 31, 2025, a decrease of -99.59%.
Revenue
7.55M
Revenue Growth
-92.17%
P/S Ratio
761.03
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.55M | -88.90M | -92.17% |
| Dec 31, 2024 | 96.45M | -47.08M | -32.80% |
| Dec 31, 2023 | 143.53M | 141.90M | 8,727.18% |
| Dec 31, 2022 | 1.63M | 191.00K | 13.31% |
| Dec 31, 2021 | 1.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinphar Pharmaceutical | 3.37B |
| Panion & Bf Biotech | 2.06B |
| Savior Lifetec | 1.20B |
| Mycenax Biotech | 740.24M |
| Pharmosa Biopharm | 67.27M |
| OBI Pharma | 58.58M |
| UnicoCell Biomed | 30.10M |
| Formosa Pharmaceuticals | 9.50M |